Standardized 2 mg starting dose
Ascendis could receive up to $285 million in total payments for this leading drug program, covering upfront fees, development, and regulatory milestones
Government programs: Medicare, Medicaid, and Tricare may cover Wegovy, but the extent of coverage varies
Available at: 3 AgarwalD.SaxenaS
Phase 2 trial data published in The New England Journal of Medicine (2023) reported up to approximately 24% total body weight reduction over 48 weeks in a dose-dependent manner
Figure 4: Photograph of Professor Georg L Zuelzer, unknown photographer and date, Historical Archive, Humboldt University, Berlin